Greenshoe

Document Security Systems, Inc. Announces Exercise of Full Over-Allotment Option by Underwriter in Public Offering

Friday, July 10, 2020 - 9:35pm

The price to the public in the offering was $6.25 per share and the gross proceeds to the Company from the exercise of the over-allotment option were approximately $964,500 before deducting underwriting discounts and commissions and other estimated offering expenses.

Key Points: 
  • The price to the public in the offering was $6.25 per share and the gross proceeds to the Company from the exercise of the over-allotment option were approximately $964,500 before deducting underwriting discounts and commissions and other estimated offering expenses.
  • The Company intends to use the net proceeds from this offering to fund development and growth of new business lines and acquisition opportunities, general corporate and working capital needs.
  • The total gross proceeds, including the full exercise of the over-allotment option, will be approximately $7.39 million from the public offering.
  • DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets.

DGAP-News: NanoViricides, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock

Thursday, July 9, 2020 - 12:03pm

The proposed offering equates to 1,369,863 million shares of the Company's common stock at a price of $7.30 per share.

Key Points: 
  • The proposed offering equates to 1,369,863 million shares of the Company's common stock at a price of $7.30 per share.
  • The Company intends to use the net proceeds from this offering for general corporate purposes and to fund ongoing operations.
  • The Company has also granted the underwriters a 45-day option to purchase up to 205,479 additional shares of common stock for potential additional gross proceeds of approximately $1.5 million before deducting underwriting discounts and other estimated offering expenses to cover over-allotments at the public offering price.
  • Kingswood Capital Markets, a division of Benchmark Investments, Inc., is acting as sole bookrunner for the offering.

Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock

Thursday, July 9, 2020 - 3:48am

REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD) today announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions.

Key Points: 
  • REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD) today announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions.
  • All of the shares of common stock are being offered by Revolution Medicines.
  • In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution Medicines, are expected to be approximately $156.0 million, excluding any exercise of the underwriters option to purchase additional shares.

Algonquin Power & Utilities Corp. Announces C$900 Million Offering of Common Shares Comprised of C$550 Million Bought Deal Offering and Concurrent C$350 Million Offering to an Institutional Investor

Wednesday, July 8, 2020 - 10:06pm

If the over-allotment option is exercised in full, the gross proceeds of the Bought Deal will be C$633 million.

Key Points: 
  • If the over-allotment option is exercised in full, the gross proceeds of the Bought Deal will be C$633 million.
  • The Common Shares offered in the Concurrent Offering are being sold directly to the institutional investor without an underwriter or placement agent.
  • The closing of the Concurrent Offering is expected to close on or about the same time as the Bought Deal.
  • The closing of the Bought Deal and the Concurrent Offering are not contingent on each other.

nCino Announces Launch of Initial Public Offering

Tuesday, July 7, 2020 - 12:30pm

WILMINGTON, N.C., July 7, 2020 /PRNewswire/ -- nCino, Inc. ("nCino") today announced that it has launched the roadshow for its initial public offering of 7,625,000 shares of its common stock.

Key Points: 
  • WILMINGTON, N.C., July 7, 2020 /PRNewswire/ -- nCino, Inc. ("nCino") today announced that it has launched the roadshow for its initial public offering of 7,625,000 shares of its common stock.
  • The underwriters of the offering will also have a 30-day option to purchase from nCino up to 1,143,750 additional shares of common stock.
  • The initial public offering price is expected to be between $22.00 and $24.00 per share.
  • nCino has applied to list its common stock onthe Nasdaq Global Select Market under the ticker symbol "NCNO."

CORRECTION: Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering

Monday, July 6, 2020 - 9:46pm

The number of Series A warrants and Series B warrants purchased by the underwriters in the over-allotment option has been corrected to 128,328.

Key Points: 
  • The number of Series A warrants and Series B warrants purchased by the underwriters in the over-allotment option has been corrected to 128,328.
  • The Series A warrants permit the holder to purchase one share of common stock at an exercise price of $9.00 and expire after 5 years.
  • The Companys common stock began trading on the Nasdaq Capital Market under the ticker symbol ADTX on June 30, 2020.
  • Sheppard, Mullin, Richter, & Hampton LLP acted as counsel to the Company in the offering.

TransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment Option

Monday, July 6, 2020 - 9:05pm

A total of 42,857,142 shares of common stock were issued in the offering, including the full exercise of the over-allotment option, at a public offering price of $0.35 per share, with total net proceeds of approximately $13.7 million.

Key Points: 
  • A total of 42,857,142 shares of common stock were issued in the offering, including the full exercise of the over-allotment option, at a public offering price of $0.35 per share, with total net proceeds of approximately $13.7 million.
  • The Company currently intends to use the net proceeds of this offering for general corporate purposes, including working capital.
  • Ladenburg Thalmann & Co. Inc. acted as sole book-running manager in connection with the offering.
  • This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the intended use of proceeds from the offering.

Chiasma Announces Pricing of a Public Offering of $70 Million of Common Stock and Pre-Funded Warrants

Wednesday, July 1, 2020 - 2:05pm

The public offering price of each share of common stock is $4.00 and the public offering price of each pre-funded warrant is $3.9999 per underlying share.

Key Points: 
  • The public offering price of each share of common stock is $4.00 and the public offering price of each pre-funded warrant is $3.9999 per underlying share.
  • In addition, Chiasma has granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares of its common stock at the public offering price, less underwriting discounts and commissions.
  • This offering is expected to close on or about July 6, 2020, subject to satisfaction of customary closing conditions.
  • Jefferies, Piper Sandler & Co. and Cantor are acting as book-running managers for the offering.

TravelCenters of America Announces Pricing of $85.4 Million Public Offering of Common Stock

Tuesday, June 30, 2020 - 11:54pm

TravelCenters of America Inc. (Nasdaq: TA) today announced the pricing of a public offering of 6,100,000 shares of its common stock at a public offering price of $14.00 per share.

Key Points: 
  • TravelCenters of America Inc. (Nasdaq: TA) today announced the pricing of a public offering of 6,100,000 shares of its common stock at a public offering price of $14.00 per share.
  • Gross proceeds from the offering are expected to be $85.4 million, before deducting underwriting discounts and commissions and other offering expenses payable by TA.
  • In addition, TA has granted the underwriters a 30-day option to purchase up to an additional 915,000 shares of its common stock, at the public offering price less underwriting discounts and commissions.
  • THIS PRESS RELEASE STATES THAT THE UNDERWRITERS HAVE BEEN GRANTED AN OPTION TO PURCHASE 915,000 ADDITIONAL SHARES OF TAS COMMON STOCK.

Fusion Acquisition Corp. Announces Closing of $350,000,000 Million Initial Public Offering

Tuesday, June 30, 2020 - 9:15pm

NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Fusion Acquisition Corp (NYSE: FUSE.U) (the Company) today announced that it closed its initial public offering of 35,000,000 units, including 4,500,000 units issued pursuant to the exercise by the underwriters of their over-allotment option.

Key Points: 
  • NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Fusion Acquisition Corp (NYSE: FUSE.U) (the Company) today announced that it closed its initial public offering of 35,000,000 units, including 4,500,000 units issued pursuant to the exercise by the underwriters of their over-allotment option.
  • Fusion Acquisition Corp. is a blank-check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of warrants, $350,000,000 (or $10.00 per unit sold in the public offering) was placed in trust.
  • This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and search for an initial business combination.